EBS Overview
Upcoming Projects (EBS)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (EBS)
-
Comparing Opiant Pharmaceuticals' OPNT003 with Emergent Biosolutions' Narcan in the opioid reversal agent landscape
Tickers: OPNT, EBS
Executed On: Sep 08, 2022 at 01:00 PM EDT -
Monkeypox Expert Survey: Concerns and Treatment Needs
Tickers: SIGA, CMRX, EBS, BVNRY
Executed On: Aug 04, 2022 at 12:27 PM EDT
Upcoming & Overdue Catalysts (EBS)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (EBS)
-
U.S Department of Health Issues $30.5M Task Order to Emergent Bio (EBS) to Develop Therapeutics for Viral Hemorrhagic Fever
Ticker: EBS
Occurred on: Feb 13, 2017 -
Emergent Bio (EBS) Wins $911MM BioThrax Contact with U.S Centers for Disease Control Prevention (CDC)
Ticker: EBS
Occurred on: Dec 09, 2016 -
Emergent BioSolutions Receives Favorable IRS Private Letter Ruling in Connection With its Planned Biosciences Business Spin-Off
Ticker: EBS
Occurred on: Jan 10, 2016 -
Emergent BioSolutions (EBS) to complete Phase 1 study of Biothrax (Anthrax) vaccine in Pregnancy Registry in July 2017
Ticker: EBS
Occurred on: Sep 01, 2015
Strategic Initiatives (EBS)
-
Emergent Bio (EBS) and Integrated Biotherapeutics Announce Deal to Develop Hyperimmunoglobulin for Filovirus-Associated Hemorrhagic Fever
Tickers: EBS, Integrated Biotherapeutics
Announcement Date: Nov 15, 2016